Founded by Mitchell H. Gold, Alpine BioVentures focuses on investing in rounds with 2-3 participants, with notable sponsors including Frazier Healthcare Partners and OrbiMed. The fund primarily invests in startups that are 1 year old or less and has a portfolio that includes companies like Alpine Immune Sciences. Deals in the range of $10-50 million are typical for the fund, which is involved in less than 2 deals per year. With a science-based and long-term approach, Alpine BioVentures partners with its portfolio companies to drive disruptive scientific changes that improve patients' lives.